ACHILLION PHARMACEUTICALS IN's ticker is and the CUSIP is 00448Q901. A total of 4 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $172,000 | -36.3% | 286 | -61.9% | 0.00% | -100.0% |
| Q3 2019 | $270,000 | +26900.0% | 751 | +10628.6% | 0.00% | – |
| Q2 2019 | $1,000 | -98.0% | 7 | -95.9% | 0.00% | – |
| Q1 2019 | $50,000 | – | 171 | +17000.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 1 | -99.3% | 0.00% | – |
| Q3 2018 | $51,000 | +920.0% | 139 | +672.2% | 0.00% | – |
| Q2 2018 | $5,000 | – | 18 | +125.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 8 | -95.6% | 0.00% | – |
| Q4 2017 | $1,000 | -83.3% | 181 | +26.6% | 0.00% | – |
| Q3 2017 | $6,000 | +200.0% | 143 | +24.3% | 0.00% | – |
| Q2 2017 | $2,000 | -33.3% | 115 | +25.0% | 0.00% | – |
| Q1 2017 | $3,000 | – | 92 | -44.2% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 165 | -69.9% | 0.00% | -100.0% |
| Q3 2016 | $29,000 | +480.0% | 548 | +162.2% | 0.00% | – |
| Q2 2016 | $5,000 | -28.6% | 209 | +2.0% | 0.00% | -100.0% |
| Q1 2016 | $7,000 | -70.8% | 205 | +1.5% | 0.00% | -50.0% |
| Q4 2015 | $24,000 | -72.1% | 202 | -51.2% | 0.00% | -66.7% |
| Q3 2015 | $86,000 | +2766.7% | 414 | +345.2% | 0.01% | – |
| Q2 2015 | $3,000 | -57.1% | 93 | -5.1% | 0.00% | -100.0% |
| Q1 2015 | $7,000 | -96.7% | 98 | -95.4% | 0.00% | -96.2% |
| Q4 2014 | $215,000 | – | 2,144 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 9,039 | $7,322,000 | 0.27% |
| GROUP ONE TRADING, L.P. | 67,900 | $550,000 | 0.01% |
| SIMPLEX TRADING, LLC | 548 | $29,000 | 0.00% |